Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 8.93 M8.16 M7.26 M9.57 M9.62 M 34.62 M Research & development ————— — Operating income 5.08 M6.57 M8.96 M10 M7.62 M 33.16 M Non-Operating Income, Total 458 K95 K313 K911 K996 K 2.31 M Interest expense, net of interest capitalized 567 K1.77 M3.98 M5.82 M7.89 M 19.46 M Non-Operating Income, excl. Interest Expenses -109 K-1.67 M-3.67 M-4.91 M-6.89 M -17.15 M Unusual income/expense ————— — Pretax income 10.67 M10.48 M9.4 M9.64 M3.64 M 33.16 M Equity in earnings ————— — Taxes 105 K72 K44 K86 K69 K 271 K Non-controlling/minority interest 12 K14 K12 K14 K5 000 45 K After tax other income/expense ————— — Net income before discontinued operations 10.56 M10.41 M9.36 M9.55 M3.57 M 32.89 M Discontinued operations ————— — Net income 10.56 M10.41 M9.36 M9.55 M3.57 M 32.89 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 10.55 M10.39 M9.35 M9.54 M3.56 M 32.84 M Basic earnings per share (Basic EPS) 0.10.10.090.080.03 0.3 Diluted earnings per share (Diluted EPS) 0.10.10.090.080.03 0.3 Average basic shares outstanding 104.91 M105 M105 M104.99 M105.08 M — Diluted shares outstanding 105.14 M105.24 M105.26 M105.3 M106.38 M — EBITDA 5.33 M6.92 M9.43 M10.53 M8.19 M 35.07 M EBIT 5.08 M6.57 M8.96 M10 M7.62 M 33.16 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 253 K354 K460 K523 K573 K 1.91 M